{"id":"https://openalex.org/W2172300766","doi":"https://doi.org/10.1093/jnci/dji053","title":"Importance of Communication Between Producers and Consumers of Publicly Available Experimental Data","display_name":"Importance of Communication Between Producers and Consumers of Publicly Available Experimental Data","publication_year":2005,"publication_date":"2005-02-15","ids":{"openalex":"https://openalex.org/W2172300766","doi":"https://doi.org/10.1093/jnci/dji053","mag":"2172300766","pmid":"https://pubmed.ncbi.nlm.nih.gov/15713967"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/dji053","doi":"https://doi.org/10.1093/jnci/dji053","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/dji053","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086886026","display_name":"Lance A. Liotta","orcid":"https://orcid.org/0000-0001-5155-7907","observed_orcids":["https://orcid.org/0000-0001-5155-7907"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"L. A. Liotta","raw_affiliation_strings":["FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD 20892, USA","Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082511886","display_name":"Mark S. Lowenthal","orcid":"https://orcid.org/0000-0001-5795-8824","observed_orcids":["https://orcid.org/0000-0001-5795-8824"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Lowenthal","raw_affiliation_strings":["Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108500070","display_name":"Arpita I. Mehta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Mehta","raw_affiliation_strings":["Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080595928","display_name":"Thomas P. Conrads","orcid":"https://orcid.org/0000-0003-4742-3281","observed_orcids":["https://orcid.org/0000-0003-4742-3281"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. P. Conrads","raw_affiliation_strings":["Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019010663","display_name":"Timothy D. Veenstra","orcid":"https://orcid.org/0000-0003-2941-0225","observed_orcids":["https://orcid.org/0000-0003-2941-0225"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. D. Veenstra","raw_affiliation_strings":["Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087545302","display_name":"David A. Fishman","orcid":"https://orcid.org/0000-0002-0038-1072","observed_orcids":["https://orcid.org/0000-0002-0038-1072"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. A. Fishman","raw_affiliation_strings":["Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110611929","display_name":"EF Petricoin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. F. Petricoin","raw_affiliation_strings":["Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML); National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV); National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF); FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Affiliations of authors: FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, CCR, Bethesda, MD (LAL, AM, ML)","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"FDA-NCI Clinical Proteomics Program, Office of Cell Therapy and Gene Therapy, CBER, Food and Drug Administration, Bethesda, MD (EFP)","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Cancer Institute Biomedical Proteomics Program, Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD (TPC, TDV)","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Ovarian Cancer Early Detection Program, New York University, New York, NY (DAF)","institution_ids":["https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5086886026"],"corresponding_institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I57206974"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":6.6807,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.98020228,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"97","issue":"4","first_page":"310","last_page":"314"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.7753999829292297,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10519","display_name":"Advanced Proteomics Techniques and Applications","score":0.7753999829292297,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11937","display_name":"Research Data Management Practices","score":0.14110000431537628,"subfield":{"id":"https://openalex.org/subfields/1710","display_name":"Information Systems"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.04830000177025795,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-markers","display_name":"tumor markers","score":0.824999988079071},{"id":"https://openalex.org/keywords/mass-spectrometry","display_name":"mass spectrometry","score":0.7549999952316284},{"id":"https://openalex.org/keywords/low-abundance-proteins","display_name":"low-abundance proteins","score":0.8479999899864197},{"id":"https://openalex.org/keywords/carrier-proteins","display_name":"carrier proteins","score":0.6349999904632568},{"id":"https://openalex.org/keywords/reproducibility","display_name":"reproducibility","score":0.7440000176429749},{"id":"https://openalex.org/keywords/interlaboratory-comparison","display_name":"interlaboratory comparison","score":0.7879999876022339},{"id":"https://openalex.org/keywords/data-sharing","display_name":"data sharing","score":0.546999990940094},{"id":"https://openalex.org/keywords/data-interpretation","display_name":"data interpretation","score":0.4779999852180481},{"id":"https://openalex.org/keywords/data-validation","display_name":"data validation","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C2776889888","wikidata":"https://www.wikidata.org/wiki/Q1135789","display_name":"Unintended consequences","level":2,"score":0.6036263108253479},{"id":"https://openalex.org/C187191949","wikidata":"https://www.wikidata.org/wiki/Q1138496","display_name":"Profiling (computer programming)","level":2,"score":0.5322840809822083},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.46528807282447815},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.4049035608768463},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3935049772262573},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3353436589241028},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0978650450706482},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003142","descriptor_name":"Communication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007400","descriptor_name":"Interprofessional Relations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007753","descriptor_name":"Laboratories","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016172","descriptor_name":"DNA Fingerprinting","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D020543","descriptor_name":"Proteome","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/dji053","doi":"https://doi.org/10.1093/jnci/dji053","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/dji053","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:15713967","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15713967","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"},{"id":"pmh:oai:digitalcommons.cedarville.edu:pharmaceutical_sciences_publications-1439","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.cedarville.edu/pharmaceutical_sciences_publications/447","pdf_url":null,"source":{"id":"https://openalex.org/S4377196552","display_name":"DigitalCommons-Cedarville (Cedarville University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169138485","host_organization_name":"Cedarville University","host_organization_lineage":["https://openalex.org/I169138485"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutical Sciences Faculty Publications","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1599833391","https://openalex.org/W1992730111","https://openalex.org/W2005615709","https://openalex.org/W2015506997","https://openalex.org/W2028087310","https://openalex.org/W2040131209","https://openalex.org/W2043256631","https://openalex.org/W2051301080","https://openalex.org/W2066135299","https://openalex.org/W2084898926","https://openalex.org/W2106246854","https://openalex.org/W2119908867","https://openalex.org/W2122430069","https://openalex.org/W2128432283","https://openalex.org/W2134389439","https://openalex.org/W2138482047","https://openalex.org/W2146146709","https://openalex.org/W2154639585","https://openalex.org/W2157814224","https://openalex.org/W2167244585","https://openalex.org/W2169182264","https://openalex.org/W2172007544","https://openalex.org/W2172300860"],"related_works":["https://openalex.org/W7098367816","https://openalex.org/W2141019834","https://openalex.org/W2125579305","https://openalex.org/W2058896813","https://openalex.org/W2083912603","https://openalex.org/W7095215067","https://openalex.org/W7097601316","https://openalex.org/W3164027181","https://openalex.org/W7102410095","https://openalex.org/W2033204893"],"abstract_inverted_index":{"The":[0],"application":[1],"of":[2,15,37,91,100,119,132],"mass":[3,38,75],"spectrometry":[4,39,76],"to":[5,34,49,69,94],"discover":[6],"new":[7,17,135],"cancer":[8],"biomarkers":[9],"is":[10,32,97],"in":[11],"its":[12],"infancy.":[13],"Many":[14],"these":[16],"markers":[18],"are":[19,59,73],"low-abundance":[20],"proteins":[21],"that":[22,58,107],"exist":[23],"as":[24],"fragments":[25],"associated":[26],"with":[27],"carrier":[28],"proteins.":[29],"Although":[30],"reproducibility":[31],"key":[33],"the":[35,44,98,115,120,130],"use":[36],"for":[40,61,78,85],"ion":[41],"fingerprint":[42],"analysis,":[43],"scientific":[45],"community":[46],"has":[47],"yet":[48],"establish":[50],"a":[51],"common":[52],"platform":[53],"or":[54],"standardized":[55],"operating":[56],"procedures":[57],"necessary":[60],"intra-":[62],"and":[63,104,117],"inter-laboratory":[64],"comparison.":[65],"In":[66],"an":[67],"effort":[68],"assist":[70],"others":[71],"who":[72],"perfecting":[74],"platforms":[77],"profiling,":[79],"ongoing":[80],"experimental":[81,95],"data":[82,96],"were":[83],"posted":[84],"public":[86],"consumption.":[87],"An":[88],"unintended":[89],"consequence":[90],"unrestricted":[92],"access":[93],"risk":[99],"inappropriate":[101],"conclusions":[102],"drawn":[103],"publicly":[105],"disseminated":[106],"could":[108],"have":[109],"been":[110],"avoided":[111],"by":[112],"communication":[113],"between":[114],"producers":[116],"consumers":[118],"data.":[121],"Such":[122],"disputes,":[123],"however,":[124],"should":[125],"not":[126],"divert":[127],"us":[128],"from":[129],"validation":[131],"this":[133],"promising":[134],"approach.":[136]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}